{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:52:29Z","timestamp":1791661949854,"version":"4.3.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2017A020213030"],"award-info":[{"award-number":["2017A020213030"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102313"],"award-info":[{"award-number":["82102313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603641"],"award-info":[{"award-number":["81603641"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81704098"],"award-info":[{"award-number":["81704098"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774339"],"award-info":[{"award-number":["81774339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["62,63"],"award-info":[{"award-number":["62,63"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["XK201912"],"award-info":[{"award-number":["XK201912"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1024314"],"award-info":[{"award-number":["1024314"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1107828"],"award-info":[{"award-number":["1107828"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1127156"],"award-info":[{"award-number":["1127156"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1027932"],"award-info":[{"award-number":["1027932"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ21H060009"],"award-info":[{"award-number":["LQ21H060009"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.biopha.2022.113622","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T09:33:58Z","timestamp":1662543238000},"page":"113622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Thiaplakortone B attenuates RANKL\u2010induced NF\u2010\u03baB and MAPK signaling and dampens OVX\u2010induced bone loss in mice"],"prefix":"10.1016","volume":"154","author":[{"given":"Qingqing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Kuek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiake","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1016\/j.biopha.2022.113622_bib1","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.2215\/CJN.04151206","article-title":"Normal bone anatomy and physiology","volume":"Suppl 3","author":"Clarke","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol. 3"},{"issue":"9773","key":"10.1016\/j.biopha.2022.113622_bib2","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2022.113622_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-019-1819-1","article-title":"Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis","volume":"17","author":"Wehrhan","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2022.113622_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00679","article-title":"Osteoimmunology of bone loss in inflammatory rheumatic diseases","volume":"10","author":"Coury","year":"2019","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2022.113622_bib5","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.joca.2016.05.015","article-title":"The anti-NGF antibody muMab 911 both prevents and reverses pain behaviour and subchondral osteoclast numbers in a rat model of osteoarthritis pain","volume":"24","author":"Xu","year":"2016","journal-title":"Osteoarthr. Cartil."},{"issue":"12","key":"10.1016\/j.biopha.2022.113622_bib6","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/rheumatology\/kew430","article-title":"Adult Paget\u2019s disease of bone: a review","volume":"56","author":"Paul Tuck","year":"2017","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.biopha.2022.113622_bib7","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1002\/jor.22714","article-title":"Osteoclast inhibition impairs chondrosarcoma growth and bone destruction","volume":"32","author":"Otero","year":"2014","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.biopha.2022.113622_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01291","article-title":"Targeting anion exchange of osteoclast, a new strategy for preventing wear particles induced- osteolysis","volume":"9","author":"Wu","year":"2018","journal-title":"Front Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2022.113622_bib9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.biopha.2022.113622_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","author":"Hernlund","year":"2013","journal-title":"Arch. Osteoporos. 8(1-2)"},{"key":"10.1016\/j.biopha.2022.113622_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bone.2019.04.010","article-title":"Pharmacogenomics of osteonecrosis of the jaw","volume":"124","author":"Yang","year":"2019","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.biopha.2022.113622_bib12","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/annonc\/mdy212","article-title":"Different menopausal hormone regimens and risk of breast cancer","volume":"29","author":"Brusselaers","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2022.113622_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.abb.2014.06.017","article-title":"The Great Beauty of the osteoclast","volume":"558","author":"Cappariello","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"issue":"12","key":"10.1016\/j.biopha.2022.113622_bib14","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.190.12.1741","article-title":"Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors","volume":"190","author":"Arai","year":"1999","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.biopha.2022.113622_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"issue":"7722","key":"10.1016\/j.biopha.2022.113622_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-018-0482-7","article-title":"Coupling of bone resorption and formation by RANKL reverse signalling","volume":"561","author":"Ikebuchi","year":"2018","journal-title":"Nature"},{"issue":"6937","key":"10.1016\/j.biopha.2022.113622_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biopha.2022.113622_bib18","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1172\/JCI94606","article-title":"The many ways of osteoclast activation","volume":"127","author":"Lorenzo","year":"2017","journal-title":"J. Clin. Invest"},{"issue":"4","key":"10.1016\/j.biopha.2022.113622_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/er.2015-1114","article-title":"Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned","volume":"38","author":"Drake","year":"2017","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2022.113622_bib20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1359\/jbmr.081239","article-title":"Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption","volume":"24","author":"Wu","year":"2009","journal-title":"J. Bone Min. Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113622_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/jpet.114.221176","article-title":"VX-509 (Decernotinib) is a potent and selective janus kinase 3 inhibitor that attenuates inflammation in animal models of autoimmune disease","volume":"353","author":"Mahajan","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.biopha.2022.113622_bib22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1021\/acsmedchemlett.8b00368","article-title":"Marine natural products in medicinal chemistry","volume":"9","author":"Jim\u00e9nez","year":"2018","journal-title":"ACS Med Chem. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2022.113622_bib23","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"3","key":"10.1016\/j.biopha.2022.113622_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"International Natural Product Sciences, C.T. Supuran, natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Disco"},{"key":"10.1016\/j.biopha.2022.113622_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.phytochem.2012.09.019","article-title":"Pyridocoumarin, aristolactam and aporphine alkaloids from the Australian rainforest plant Goniothalamus australis","volume":"86","author":"Levrier","year":"2013","journal-title":"Phytochemistry"},{"issue":"24","key":"10.1016\/j.biopha.2022.113622_bib26","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.1016\/j.bmc.2012.09.052","article-title":"Synthesis and antimalarial evaluation of a screening library based on a tetrahydroanthraquinone natural product scaffold","volume":"20","author":"Choomuenwai","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2022.113622_bib27","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1021\/jm3002795","article-title":"Antimalarial activity of pyrroloiminoquinones from the Australian marine sponge Zyzzya sp","volume":"55","author":"Davis","year":"2012","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2022.113622_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.tetlet.2009.11.055","article-title":"(+)-7-Bromotrypargine: an antimalarial \u03b2-carboline from the Australian marine sponge Ancorina sp","volume":"51","author":"Davis","year":"2010","journal-title":"Tetrahedron Lett."},{"issue":"19","key":"10.1016\/j.biopha.2022.113622_bib29","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1021\/jo400988y","article-title":"Thiaplakortones A\u2013D: antimalarial thiazine alkaloids from the Australian marine sponge plakortis lita","volume":"78","author":"Davis","year":"2013","journal-title":"J. Org. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2022.113622_bib30","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1039\/C4OB01849D","article-title":"Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold","volume":"13","author":"Schwartz","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2022.113622_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1021\/ml400447v","article-title":"Total synthesis of thiaplakortone A: derivatives as metabolically stable leads for the treatment of malaria","volume":"5","author":"Pouwer","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.biopha.2022.113622_bib32","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1359\/jbmr.2000.15.11.2178","article-title":"Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF-\u03baB ligand","volume":"15","author":"Xu","year":"2000","journal-title":"J. Bone Miner. Res."},{"issue":"18","key":"10.1016\/j.biopha.2022.113622_bib33","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1073\/pnas.85.18.6706","article-title":"cDNA cloning and expression of murine macrophage colony-stimulating factor from L929 cells","volume":"85","author":"Ladner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biopha.2022.113622_bib34","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/jbmr.4025","article-title":"Hymenialdisine: a marine natural product that acts on both osteoblasts and osteoclasts and prevents estrogen-dependent bone loss in mice","volume":"35","author":"Wang","year":"2020","journal-title":"J. Bone Min. Res."},{"issue":"12","key":"10.1016\/j.biopha.2022.113622_bib35","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1359\/jbmr.2003.18.12.2159","article-title":"12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-Induced NF-\u03baB activation","volume":"18","author":"Wang","year":"2003","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.biopha.2022.113622_bib36","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1002\/jcp.30045","article-title":"A missense mutation sheds light on a novel structure\u2013function relationship of RANKL","volume":"236","author":"Qiu","year":"2020","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.biopha.2022.113622_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.metabol.2018.02.011","article-title":"Effects of ovariectomy and exercise training intensity on energy substrate and hepatic lipid metabolism, and spontaneous physical activity in mice","volume":"83","author":"Tuazon","year":"2018","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.biopha.2022.113622_bib38","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.7150\/thno.30206","article-title":"Pseurotin A inhibits osteoclastogenesis and prevents ovariectomized-induced bone loss by suppressing reactive oxygen species","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.biopha.2022.113622_bib39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","article-title":"Estrogen and the skeleton","volume":"23","author":"Khosla","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.biopha.2022.113622_bib40","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.biopha.2022.113622_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2017.01.024","article-title":"The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide","volume":"104","author":"Curtis","year":"2017","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.biopha.2022.113622_bib42","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.3390\/md13095784","article-title":"Synthesis and antiplasmodial evaluation of analogues based on the tricyclic core of thiaplakortones A-D","volume":"13","author":"Schwartz","year":"2015","journal-title":"Mar. Drugs"},{"issue":"12","key":"10.1016\/j.biopha.2022.113622_bib43","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","article-title":"Pathogenesis of osteoporosis: concepts, conflicts, and prospects","volume":"115","author":"Raisz","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.biopha.2022.113622_bib44","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.clinbiochem.2012.03.021","article-title":"An overview of the regulation of bone remodelling at the cellular level","volume":"45","author":"Kular","year":"2012","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2022.113622_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1749-6632.2009.05245.x","article-title":"Integrins, growth factors, and the osteoclast cytoskeleton","volume":"1192","author":"Zou","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"19","key":"10.1016\/j.biopha.2022.113622_bib46","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.7150\/thno.28391","article-title":"V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis","volume":"8","author":"Duan","year":"2018","journal-title":"Theranostics"},{"issue":"42","key":"10.1016\/j.biopha.2022.113622_bib47","doi-asserted-by":"crossref","first-page":"35209","DOI":"10.1074\/jbc.M505815200","article-title":"Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis","volume":"280","author":"Kim","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.biopha.2022.113622_bib48","doi-asserted-by":"crossref","first-page":"45969","DOI":"10.1074\/jbc.M408795200","article-title":"Essential Role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1","volume":"279","author":"Matsumoto","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2022.113622_bib49","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/tox.21784","article-title":"Fluoride decreased osteoclastic bone resorption through the inhibition of NFATc1 gene expression","volume":"29","author":"Pei","year":"2012","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113622_bib50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2009.00821.x","article-title":"Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation","volume":"231","author":"Negishi-Koga","year":"2009","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2022.113622_bib51","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbamcr.2010.11.002","article-title":"Calcium signaling in osteoclasts","volume":"1813","author":"Hwang","year":"2011","journal-title":"Biochim Biophys. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2022.113622_bib52","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1196\/annals.1402.071","article-title":"The role of NFAT in osteoclast formation","volume":"1116","author":"Takayanagi","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2022.113622_bib53","article-title":"Focus on the p38 MAPK signaling pathway in bone development and maintenance","volume":"4","author":"Thouverey","year":"2015","journal-title":"Bone Rep."},{"issue":"2","key":"10.1016\/j.biopha.2022.113622_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol. Res."},{"issue":"51","key":"10.1016\/j.biopha.2022.113622_bib55","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-\u03baB: players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2022.113622_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cr.2010.177","article-title":"Non-canonical NF-\u03baB signaling pathway","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.113622_bib57","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1083\/jcb.148.2.333","article-title":"Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts","volume":"148","author":"Miyazaki","year":"2000","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113622_bib58","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1359\/jbmr.080211","article-title":"JNK\/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts","volume":"23","author":"Ikeda","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.113622_bib59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbrc.2006.10.011","article-title":"Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway","volume":"351","author":"Huang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2022.113622_bib60","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.1111\/jcmm.14713","article-title":"Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis","volume":"23","author":"Jin","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.113622_bib61","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1096\/fj.201800883RRR","article-title":"Cumambrin A prevents OVX\u2010induced osteoporosis via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways","volume":"33","author":"Zhou","year":"2019","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.biopha.2022.113622_bib62","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/molecules22101715","article-title":"Screening a natural product-based library against kinetoplastid parasites","volume":"22","author":"Zulfiqar","year":"2017","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.biopha.2022.113622_bib63","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1039\/C8CC00090E","article-title":"Selective protein unfolding: a universal mechanism of action for the development of irreversible inhibitors","volume":"54","author":"Askin","year":"2018","journal-title":"Chem. Commun."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222010113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:47:00Z","timestamp":1791661620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222010113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":63,"alternative-id":["S0753332222010113"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113622","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thiaplakortone B attenuates RANKL\u2010induced NF\u2010\u03baB and MAPK signaling and dampens OVX\u2010induced bone loss in mice","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113622"}}